Cathie Wood’s ARK sells Roblox stock, buys SpaceX
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GeneDx Holdings Corp (WGS)
Track today's live GeneDx Holdings (WGS) share price, performance and key data on this page with our current NASDAQ:WGS stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the GeneDx Holdings share price on the NASDAQ exchange. Use the dropdown to switch exchange for the WGS share price, head to our technical summary section, which provides analysis on GeneDx Holdings share price buy/sell indicators using real-time data (or discuss the GeneDx Holdings (WGS) stock price today with other investors in the GeneDx Holdings NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:WGS share price (ISIN: US81663L2007) to enhance your trading decisions with our free investment tools and resources.
What Is the GeneDx Holdings Corp Share Price Today?
The GeneDx Holdings share price today is 77.08.
What Is the Stock Symbol for GeneDx Holdings Corp
The stock symbol (or 'ticker') for GeneDx Holdings Corp is "WGS."
What Stock Exchange Does GeneDx Holdings Corp Trade On?
GeneDx Holdings Corp is listed and trades on the NASDAQ stock exchange.
Is GeneDx Holdings Corp a Good Stock to Buy?
Determining whether GeneDx Holdings (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:WGS share price (ISIN: US81663L2007) to enhance your trading decisions with our free investment tools and resources.
What Is the GeneDx Holdings Corp Share Price Today?
The GeneDx Holdings share price today is 77.08.
What Is the Stock Symbol for GeneDx Holdings Corp
The stock symbol (or 'ticker') for GeneDx Holdings Corp is "WGS."
What Stock Exchange Does GeneDx Holdings Corp Trade On?
GeneDx Holdings Corp is listed and trades on the NASDAQ stock exchange.
Is GeneDx Holdings Corp a Good Stock to Buy?
Determining whether GeneDx Holdings (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
69.61
78.23
52 wk Range
32.21
170.87
WGS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
69.6178.23
52 wk Range
32.21170.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WGS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
85.89
Upside
+11.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 85.89
(+11.43% Upside)
GeneDx Holdings Corp Earnings Call Summary for Q2/2026
- GeneDx Q2 revenue hit $114.4M, beating forecasts by 3.05%; achieved adjusted net income of $0.4M one quarter ahead of plan despite EPS miss of $0.28.
- Exome and genome test volume surged 32% YoY to record 30,785 tests; gross margin improved to 70% after completing $25M in annual cost reductions.
- Shares jumped 15.1% to $75 in after-hours trading on strong volume growth and earlier-than-expected profitability milestone.
- Company reaffirmed 2026 guidance of $475M-$490M revenue with 30%+ volume growth; Q3 revenue expected at $122M-$124M with ~$2M adjusted net income.
- Management prioritizes revenue cycle improvements to boost collection rates toward 70% industry standard, with biggest gains expected in 2027 from payer coverage.
Last Updated: 03/08/2026, 22:40
Read Full TranscriptEarnings
Latest Release
03/08/2026
EPS / Forecast
-0.28 / -0.14
Revenue / Forecast
114.4M / 111.01M
Compare WGS to Peers and Sector
Metrics to compare | WGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.6x | −46.5x | −0.4x | |
PEG Ratio | 0.00 | 0.52 | 0.00 | |
Price/Book | 9.4x | 3.0x | 2.6x | |
Price / LTM Sales | 5.1x | 1.7x | 3.1x | |
Upside (Analyst Target) | 16.8% | 15.1% | 48.8% | |
Fair Value Upside | Unlock | −7.3% | 5.7% | Unlock |
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GeneDx Holdings (NASDAQ: WGS) Share Price Today?
The GeneDx Holdings stock price today is 77.08 USD.
What Stock Exchange Does GeneDx Holdings (WGS) Trade On?
GeneDx Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for GeneDx Holdings?
The stock symbol (also called a 'ticker') for GeneDx Holdings is "WGS."
What Is the Current GeneDx Holdings Market Capitalisation?
As of today, GeneDx Holdings (NASDAQ: WGS) market cap is 2.30B USD.
What Is GeneDx Holdings's (WGS) Earnings Per Share (TTM)?
The GeneDx Holdings EPS is currently -3.64 (Trailing Twelve Months).
When Is the Next GeneDx Holdings Earnings Date?
GeneDx Holdings's next earnings report will be released on 03/11/2026.
Is WGS a Buy or Sell From a Technical Analyst Perspective?
Based on today's GeneDx Holdings moving averages and other technical indicators, the daily buy/sell signal for WGS stock is Strong Buy.
How Many Times Has GeneDx Holdings Stock Split?
GeneDx Holdings has split 1 times. (See the WGS stock split history page for full effective split date and price information.)
How Many Employees Does GeneDx Holdings Have?
GeneDx Holdings has 1300 employees, based on their latest Companies House report.
What is the current trading status of GeneDx Holdings (NASDAQ: WGS)?
As of 09/08/2026, GeneDx Holdings (WGS) is trading at a share price of 77.08 USD, with a previous close of 69.59 USD. The stock has fluctuated within a day range of 69.61 USD to 78.23 USD, while its 52-week range spans from 32.21 USD to 170.87 USD.
What Is GeneDx Holdings (WGS) Price Target According to Analysts?
The average 12-month price target for GeneDx Holdings is 85.89 USD, with a high estimate of 103 USD and a low estimate of 63 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +11.43% Upside potential.
What Is the WGS Premarket Price?
WGS's last pre-market stock price is 70.36 USD. The pre-market share volume is 1,010.00, and the stock has decreased by 0.77, or 1.11%.
What Is the WGS After Hours Price?
WGS's last after hours stock price is 76.94 USD, the stock has decreased by -0.14, or -0.18%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.